98 related articles for article (PubMed ID: 28235624)
1. Design of novel injectable in-situ forming scaffolds for non-surgical treatment of periapical lesions: In-vitro and in-vivo evaluation.
Shamma RN; Elkasabgy NA; Mahmoud AA; Gawdat SI; Kataia MM; Abdel Hamid MA
Int J Pharm; 2017 Apr; 521(1-2):306-317. PubMed ID: 28235624
[TBL] [Abstract][Full Text] [Related]
2. Polymeric and Non Polymeric Injectable In-situ Forming Implant Systems for Sustained Delivery of Lornoxicam: In vitro and In vivo Evaluation.
Yehia SA; Halim SAA; Aziz MY
Curr Drug Deliv; 2018; 15(8):1193-1203. PubMed ID: 29557743
[TBL] [Abstract][Full Text] [Related]
3. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
4. Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration.
Zhang Z; Bi X; Li H; Huang G
Drug Deliv; 2011; 18(7):536-44. PubMed ID: 21812757
[TBL] [Abstract][Full Text] [Related]
5. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility and osteogenesis of calcium phosphate composite scaffolds containing simvastatin-loaded PLGA microspheres for bone tissue engineering.
Zhang HX; Xiao GY; Wang X; Dong ZG; Ma ZY; Li L; Li YH; Pan X; Nie L
J Biomed Mater Res A; 2015 Oct; 103(10):3250-8. PubMed ID: 25809455
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Evaluations of Mangiferin-Loaded PLGA Scaffolds for Alveolar Bone Repair Treatment Under the Diabetic Condition.
Li H; Liao H; Bao C; Xiao Y; Wang Q
AAPS PharmSciTech; 2017 Feb; 18(2):529-538. PubMed ID: 27126006
[TBL] [Abstract][Full Text] [Related]
8. Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam.
Christian R; Thakkar V; Patel T; Gohel M; Baldaniya L; Shah P; Pandya T; Gandhi T
Curr Drug Deliv; 2019; 16(1):66-78. PubMed ID: 30264681
[TBL] [Abstract][Full Text] [Related]
9. Long lasting in-situ forming implant loaded with raloxifene HCl: An injectable delivery system for treatment of bone injuries.
Elkasabgy NA; Abdel-Salam FS; Mahmoud AA; Basalious EB; Amer MS; Mostafa AA; Elkheshen SA
Int J Pharm; 2019 Nov; 571():118703. PubMed ID: 31536761
[TBL] [Abstract][Full Text] [Related]
10. Physicomechanical properties of sintered scaffolds formed from porous and protein-loaded poly(DL-lactic-co-glycolic acid) microspheres for potential use in bone tissue engineering.
Boukari Y; Scurr DJ; Qutachi O; Morris AP; Doughty SW; Rahman CV; Billa N
J Biomater Sci Polym Ed; 2015; 26(12):796-811. PubMed ID: 26065672
[TBL] [Abstract][Full Text] [Related]
11. Fabrication and evaluation of a sustained-release chitosan-based scaffold embedded with PLGA microspheres.
Song K; Liu Y; Macedo HM; Jiang L; Li C; Mei G; Liu T
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1506-13. PubMed ID: 23827602
[TBL] [Abstract][Full Text] [Related]
12. Effects of hesperidin loaded poly(lactic-co-glycolic acid) scaffolds on growth behavior of costal cartilage cells in vitro and in vivo.
Cho SA; Cha SR; Park SM; Kim KH; Lee HG; Kim EY; Lee D; Khang G
J Biomater Sci Polym Ed; 2014; 25(6):625-40. PubMed ID: 24588773
[TBL] [Abstract][Full Text] [Related]
13. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
Lu Y; Yu Y; Tang X
J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
[TBL] [Abstract][Full Text] [Related]
14. Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots.
Wang JW; Xu JH; Li J; Zhao MH; Zhang HF; Liu DC; Zhou X; Xu H
J Pharm Sci; 2016 Jan; 105(1):205-11. PubMed ID: 26566075
[TBL] [Abstract][Full Text] [Related]
15. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
[TBL] [Abstract][Full Text] [Related]
16. Effects of Nano-hydroxyapatite/Poly(DL-lactic-co-glycolic acid) Microsphere-Based Composite Scaffolds on Repair of Bone Defects: Evaluating the Role of Nano-hydroxyapatite Content.
He S; Lin KF; Sun Z; Song Y; Zhao YN; Wang Z; Bi L; Liu J
Artif Organs; 2016 Jul; 40(7):E128-35. PubMed ID: 27378617
[TBL] [Abstract][Full Text] [Related]
17. Development of PLGA-coated β-TCP scaffolds containing VEGF for bone tissue engineering.
Khojasteh A; Fahimipour F; Eslaminejad MB; Jafarian M; Jahangir S; Bastami F; Tahriri M; Karkhaneh A; Tayebi L
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():780-8. PubMed ID: 27612772
[TBL] [Abstract][Full Text] [Related]
18. Boron containing poly-(lactide-co-glycolide) (PLGA) scaffolds for bone tissue engineering.
Doğan A; Demirci S; Bayir Y; Halici Z; Karakus E; Aydin A; Cadirci E; Albayrak A; Demirci E; Karaman A; Ayan AK; Gundogdu C; Sahin F
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():246-53. PubMed ID: 25280703
[TBL] [Abstract][Full Text] [Related]
19. Facile fabrication of poly(L-lactic acid)-grafted hydroxyapatite/poly(lactic-co-glycolic acid) scaffolds by Pickering high internal phase emulsion templates.
Hu Y; Gu X; Yang Y; Huang J; Hu M; Chen W; Tong Z; Wang C
ACS Appl Mater Interfaces; 2014 Oct; 6(19):17166-75. PubMed ID: 25243730
[TBL] [Abstract][Full Text] [Related]
20. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications.
Shi X; Wang Y; Ren L; Huang W; Wang DA
Int J Pharm; 2009 May; 373(1-2):85-92. PubMed ID: 19429292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
